RealFeedApp GSK gets approval for new cancer type
GSK has received FDA approval for a new cancer indication, unveiled initial data from a global study of next-generation chemotherapy, and highlighted a licensed medicine in a presidential session.
- Field
- industry news
- What they did
- GSK is seeing its return to oncology start to pay off, as a cancer drug received approval for another tumor type, the company unveiled the first data from a global study of a promising next-generation chemotherapy, and a medicine the firm licensed got the limelight in a presidential session.
- Why it matters
- This could be beneficial for patients with various tumor types, as it expands access to new cancer treatment methods.
#gsk#oncology#fda approval#chemotherapy#clinical trial
